submission of Monitoring Agency report for the Q1 2027

www.capillarytech.com Date: August 04, 2026 To To, BSE Limited National Stock Exchange of India Limited Listing Department Listing Department Phiroze JeeJeebhoy Towers, Dalal Exchange Plaza , Bandra Kurla Complex Street Fort, Mumbai -400001 Bandra (East), Mumbai -4000051 Scrip Code: 544614 Symbol: CAPILLARY Dear Sir/Madam SUBJECT: MONITORING AGENCY REPORT FOR THE QUARTER ENDED JUNE 30, 2026. Pursuant to Regulation 32 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), read with Regulation 41 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, we hereby submit the Monitoring Agency Report dated August 04, 2026, issued by CRISIL Ratings Limited, Monitoring Agency, for the quarter ended June 30, 2026, in respect of utilisation of proceeds of the Initial Public Offer (“IPO”) of the Company. The said report is duly reviewed by the Audit Committee of the Company at its meeting held on August 04, 2026, and the same is enclosed herewith. This Monitoring agency report will also be made available on the website of the Company and can be accessed using the below link: https://www.capillarytech.com/investors/shareholder-information/corporate- announcements/ We request you to take the above information on records. Yours faithfully, For Capillary Technologies India Limited Gireddy Bhargavi Reddy Company Secretary and Compliance Officer Membership No. A17091 Place: Bengaluru Encl: As above Capillary Technologies India Limited CIN- L72200KA2012PLC063060 Regd. Office - 360, bearing PID No: 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru, Karnataka 560102 Email: secretarial@capillarytech.com Website: www.capillarytech.com Tel: 080-41225179 Monitoring Agency Report Capillary Technologies India Limited for the quarter ended June 30, 2026 CRL/MAR/ CATIPI/2026-27/1919 August 04, 2026 Capillary Technologies India Limited #360 bearing PID No 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru 560 102, Karnataka, India Dear Sir, Monitoring Agency Report for the quarter ended June 30, 2026 - in relation Initial Public Offer (“IPO”) of Capillary Technologies India Limited (“the Company”) Pursuant to Regulation 41 (2) of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (“SEBI ICDR Regulations”) and Monitoring Agency Agreement dated November 07, 2025, enclosed herewith the Monitoring Agency Report, issued by Crisil Ratings Limited, Monitoring Agency, as per Schedule XI of the SEBI ICDR Regulations towards utilization of proceeds of IPO for the quarter ended June 30, 2026. Request you to kindly take the same on records. Thanking you, For and on behalf of Crisil Ratings Limited Shounak Chakravarty Director, Ratings (LCG) Report of the Monitoring Agency (MA) Name of the issuer: Capillary Technologies India Limited For quarter ended: June 30, 2026 Name of the Monitoring Agency: Crisil Ratings Limited (a) Deviation from the objects: Not applicable (b) Range of Deviation: Not applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit-related analyses. We confirm that we do not perceive any conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Shounak Chakravarty Designation of Authorized person/Signing Authority: Director, Ratings (LCG) 1) Issuer Details: Name of the issuer: Capillary Technologies India Limited Names of the promoter: Mr. Aneesh Reddy Boddu Capillary Technologies International Pte Ltd Industry/sector to which it belongs: Software Products 2) Issue Details Issue Period: Friday, November 14, 2025, to Tuesday, November 18, 2025 Type of issue (public/rights): Initial Public Offer (IPO) Type of specified securities: Equity Shares IPO Grading, if any: NA Issue size: Rs 3,450.00 million* *Note: Particulars Amount (Rs. in million) Gross proceeds 3,450.00 # Less: Issue Expenses 220.92 Net Proceeds 3,229.08 #Crisil Ratings shall be monitoring the gross proceeds. 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information/ certifications Comments of Comments of the Particulars Reply considered by the Board of Monitoring Agency Monitoring Agency for Directors preparation of report Proceeds were utilized Management towards object 1: Funding undertaking, Peer- the cloud infrastructure reviewed Independent cost and object 4: Whether all utilization is as per Chartered Accountant Funding inorganic the disclosures in the Offer Yes certificate^, Prospectus No comments growth through Document? (hereinafter referred as unidentified acquisitions “Offer document) dated and general corporate November 18, 2025, purposes as mentioned in Bank Statements the offer document Whether shareholder approval has been obtained in case of material deviations from NA No comments No comments expenditures disclosed in the Offer Document? Whether the means of finance for the disclosed objects of the issue No No comments No comments has changed? Is there any major deviation observed over the earlier No No comments No comments monitoring agency reports? Whether all Government/ Management statutory approvals related to the NA No comments No comments Undertaking, Peer- object(s) have been obtained? reviewed Independent Whether all arrangements Chartered Accountant pertaining to technical NA certificate^ No comments No comments assistance/collaboration are in operation? Are there any favorable events improving the viability of these No No comments No comments object(s)? Are there any unfavorable events affecting the viability of the No No comments No comments object(s)? Is there any other relevant information that may materially No No comments No comments affect the decision making of the investors? NA represents Not Applicable ^Certificate dated July 26, 2026, issued by M/s Saini Pati Shah & Co LLP, Chartered Accountants (Firm Registration Number: 137904W/W100622), Peer-reviewed Independent Chartered Accountant. 4) Details of object(s) to be monitored: i. Cost of the object(s): Source of Original Comments of the Board of Directors information/ co [Showing first 8,000 characters — download PDF for full document]